Article Summary
- History of monkeypox and the role it plays in the pandemic industry business model used by the biowarfare industrial complex;
- A reminder about the Nuclear Threat Initiative’s 2021 tabletop exercise predicting a monkeypox pandemic;
- Geopolitical situation in the Democratic Republic of Congo, where the first human monkeypox case was detected and where biowarfare industry leader Mérieux Foundation happen to have biosafety level two and level three laboratories;
- A glimpse into the wealth, power, ineffectiveness and lack of safety behind mpox vaccines and therapeutics;
- The restrictions being planned and implemented in the name of mpox infection control;
- Some of the best available references to learn more about the way that monkeypox is being used to shift society towards global totalitarian rule.
Monkeypox (Rebranded as MPox)
First identified in laboratory monkeys in 1958, monkeypox is a phylogenetic cousin to smallpox, causing a milder but otherwise clinically identical disease. Prolonged direct contact with infected pustules or respiratory droplets is usually required for disease transmission.
Monkeypox symptoms include pus-filled skin lesions which can be painful, fever and influenza-like-illness. The disease is mild and self-limiting in healthy people, resolving within two to four weeks of symptom onset. As we outlined in August 2022, monkeypox symptoms can be easily confused with other rash illnesses including chickenpox, measles, bacterial skin infections, scabies, syphilis, medication-associated allergies, herpes zoster and porphyria.
These conditions are all affected by immune responses. A healthy immune system can mount a robust response with rapid resolution, whilst a weakened or malfunctioning immune system is more likely to result in more severe clinical outcomes.
In November 2022 WHO announced the renaming of “monkeypox” to “mpox”.
The MPox Public Health Emergency of International Concern (PHEIC)
On 22 July 2022, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus overruled the majority vote of the WHO expert committee and declared a monkeypox public health emergency of international concern (PHEIC). This was immediately challenged by the World Council for Health.
World Council for Health, 26 July 2022
Currently, it is not clear whether this skin disorder is indeed a monkeypox infection. Lesions shown in the media resemble shingles, herpes simplex virus, and other skin lesions. It is also not clear whether it is occurring in association with the Covid-19 genetic injections, as skin lesions are common with the latter. Independent scientists need access to the full data set on which Tedros and the WHO are basing their declaration of a monkeypox health emergency.
Ghebreyesus declared the end of the mpox PHEIC on 11 May 2023 due to an alleged sustained decline in cases. Fifteen months later, on 14 August 2024, he made a second declaration of an mpox PHEIC, claiming this was due to a new strain, Clade IB, spreading rapidly via sexual contact.
The PHEIC / Biowarfare Business Model
A week prior to the second declaration, Ghebreyesus “triggered the process for Emergency Use Listing for mpox vaccines…” Demonstrating the business model at play, vaccine manufacturer share prices immediately soared.
As outlined by NZDSOS in two previous articles, here and here, in March 2021 the Nuclear Threat Initiative ran a simulated tabletop exercise portraying a deadly monkeypox pandemic originating from a regional bio-terror attack dated 15 May 2022. By ridiculous coincidence, on 20 May 2022 CNN ran a cover story about monkeypox, just two months before Ghebreyesus announced his first Monkeypox PHEIC.
Hidden in plain sight, the biowarfare industry runs on a scheduled pattern of multi-disciplinary collusion. Investments in gain-of-function research and corresponding product manufacture (science) + simulations to model the desired biosecurity response (politics) + propaganda to raise public anxiety and compliance (media). It culminates with a PHEIC declaration to generate return on investment for the protagonists.
Situation in Democratic Republic of Congo (DRC)
The first known human case of monkeypox was detected in a nine-month-old boy in the Democratic Republic of Congo (DRC) in sub-Saharan Africa in 1970. A steadily increasing number of cases have been reported each year.
As at 20 August, 548 deaths in the DRC in 2024 have been attributed to Monkeypox. Seventy-eight per cent of suspected deaths have occurred in children under 15 years old and 30 per cent in those under five years old. This may be explained by a number of factors including immature immune systems; immune dysregulation caused by vaccination; decreased likelihood of prior exposure needed for immunity; and higher rates of immune-dysregulating conditions such as malnutrition, in children unfortunate enough to be born in what is one of the poorest nations on earth.
With a population of over 100 million people, DRC is one of only five nations where half of all the world’s under-five-year-old deaths occur. There are approximately 700,000 deaths each year in the DRC, whose crude health system includes fewer than two doctors for every 10,000 people and where, more importantly, around 75 per cent of the population exist on US$2.15 a day. The nation has been destroyed by corporate exploitation of their rich mineral resources (“conflict minerals”), excavated under appalling conditions, largely for battery components to support the so-called “Green” agenda.
The top causes of death in the DRC include neonatal conditions followed by five infectious diseases, all of which significantly affect children. Under sane and ethical circumstances, this epidemiology would drive the focus of health care expenditure towards maternal and child health, and improving living conditions such as access to clean water, requisite sanitation and adequate nutrition, and human rights protections for workers.
The conditions in DRC are a stark reminder of similar states in the cities of Europe at the turn of the last century when smallpox was rampant. It is also worth reiterating that smallpox was conquered by improvement in living conditions and isolation of the sick, well before there was a WHO. Rather than doing the hard work it was set up to do, and considering diseases such as mpox in context, WHO are now focused on meeting the needs of their private and political sponsors, at the expense of population health.
In a stark illustration of embedded corruption, pandemic preparedness via the International Health Regulations is prominent in the DRC health system. Resources are being channeled towards surveillance, globalised policy and financial structures, as well as two emergency dashboards (for covid and mpox), seemingly prioritised over the real health concerns of the population.
Unaware of the risks, impoverished health workers are being set up with digital identification and central bank digital currency. This is guaranteed to cause immense harm to increasingly powerless civilians, whilst siphoning profits and power into the hands of the central bankers and their partners/beneficiaries leading this clandestine, global coup d’état. Learn more here.
As is also occurring in New Zealand, so-called “pandemic planning” in the DRC makes no mention of gain of function research. Experimentation with viruses including monkeypox has been deliberately concealed from public scrutiny by those funding the activities.
Gain of function may well be taking place clandestinely in well-funded laboratories located in this increasingly unstable nation, such as Mérieux Foundation’s high security facility in Goma. In another ridiculous coincidence, Goma is the largest city in North Kivu Province, in eastern DRC and lies on the border with South Kivu Province where Clade IB appears to have originated.
Ravaged by conflict, corruption and poverty embedded over generations via wealth extraction practices, the people of DRC now face the cruelty of the globalist agenda being attempted across all nations.
A resource-limited health system combined with high infant and child mortality, makes the DRC a prime candidate for pseudo-epidemics amongst an already-suffering childhood population, based on flawed testing. For example, 2% of children in the DRC had severe malnutrition in 2017. This is the most recent data available and has likely worsened since global lockdown policies were implemented. Where there is enhanced testing for Monkeypox, are children dying of other causes being counted as “mpox deaths“?
The phenomenon of a pseudo-epidemic would explain contradictory claims of Clade IB transmission occurring mainly through sexual networks, whilst children are reportedly impacted the most by mpox disease. Most deaths are being reported in individuals with immune suppression such as advanced HIV. Whilst immune suppression increases the chances of severe mpox disease, it also increases the possibility of disease misclassification if singular testing is being used for diagnosis in individuals suffering and/or dying from more serious conditions. The pandemic agenda depends on a precarious foundation of falsehoods, confusion and fear.
Meanwhile, mpox surveillance systems are detecting the infection amongst other, mostly impoverished nations. Spread across the DRC borders, into Burundi, Kenya, Rwanda and Uganda may make some sense. However, it seems less believable that a virus spreading through sexual networks in impoverished sub-Saharan Africa can make its way to Pakistan, Vietnam, the Philippines, and Sweden.
MPox Generating Corporate Profits
In 2018 the US FDA approved the drug Tecovirimat, known as TPOXX, as “an additional option should smallpox ever be used as a bioweapon“. It has since been made available for treatment of mpox and it is available in New Zealand under Section 29 of the Medicines Act. TPOXX is manufactured by SIGA Technologies Inc., a biotechnology company whose primary shareholder is billionaire and political lobbyist Ron Perelman, “the richest man in New York City“.
On 15 August 2024 TPOXX trial results published no difference between mpox patients who received TPOXX and those who received a placebo. The trial results showed that supportive care such as nutrition, hydration and treatment of secondary infections significantly reduce the case fatality rate of mpox. Whilst positively impacting the health outcomes of impoverished patients, these simple interventions offer no profit to the pandemic industry. This explains why the investigators expressed disappointment at the positive outcomes of their trial!
Vaccines are ideal for maximum profits as they can be universally recommended (and/or mandated). Smallpox vaccines are being recommended against mpox, the main two being Jynneos (Bavarian Nordic) and ACAM2000 (Emergent BioSolutions).
In NZ the Jynneos brand was available as an unapproved medicine under s29 of the Medicines Act in 2022 for those deemed at risk of monkeypox. In Mar 2023 Medsafe issued a monitoring communication about pericarditis following monkeypox vaccination and health minister at the time, Dr Ayesha Verrall, was alerted to this being a potential safety signal.
Stockpiles of these vaccines and of therapeutics including TPOXX are held by the US Administration for Strategic Preparedness and Response. Creating a need for use of these stockpiles by deceitful claims of a PHEIC guarantees ongoing purchase of the products, in the cyclical economy of public funds funneled through to private profits.
Until the introduction of the Covid-19 injections, smallpox vaccines had the strongest association with myocarditis. Other listed adverse events are many and include generalised vaccinia (smallpox), encephalitis, encephalopathy, blindness and nervous system disorders. An authentic public health response to what is a mild disease for most people would never authorise, let alone recommend, products with such a high risk profile.
Informed Consent
The Universal Declaration on Bioethics and Human Rights states:
Article Six
Any preventative, diagnostic and therapeutic medical intervention is only to be carried out with the prior, free and informed consent of the person concerned, based on adequate information. The consent should, where appropriate, be express and may be withdrawn by the person concerned at any time and for any reason without disadvantage or prejudice.
Understanding the medical risks of recommended pharmaceutical products and the geopolitical background explaining why dangerous products are being pushed onto populations are important aspects of informed consent. We hope this article informs a wide audience in New Zealand and beyond, to advance the ongoing resistance against global fascism and pseudo-pandemics being led by WHO at the expense of human health and well-being.
It is becoming apparent that monkeypox is being used as a tool to reshape mobility rights of travelers, with Singapore and Indonesia both introducing testing at their international borders. This contravenes the World Health Organization’s own evidence that contact tracing, quarantine, border screening and closures are “not recommended in any circumstances“, due to low quality evidence for variable and lacking effectiveness. The obvious explanation for these interventions is to step-up planned requirements for digital surveillance, digital identity and social credit scores, described articulately by Alex Jones on the Great Reset and New World Order.
Laurent Mucchielli, sociologist and senior researcher at the National Scientific Research Centre in Paris, warns in After Covid, monkeypox: the same circus again?:
All the frameworks that we saw during the Covid crisis seem to be in the process of being reinstalled at record speed. The story begins by sewing fear in the population, and ends with a conclusion that has been prepared in advance: we are going to have to buy billions of doses of vaccines (patented of course) as a matter of urgency. It is urgent and crucial that as many of us as possible first awaken intellectually and then find the courage to publicly announce their refusal to consent.
The health workers signing up for digital identification and their patients attending rudimentary clinics and hospitals in Africa and Asia may not have the privilege of understanding what is at stake. Many are also likely to have no choice. For the time being, we have access to information and the ability to make informed choices. Now is the time to get ready to resist. Please, please share this article.
Learn More
Further information is available at the following links:
- Meryl’s Chaos Newsletter: Substack articles by biowarfare expert Dr Meryl Nass;
- What’s Really Happening with Mpox: August 2024 Brownstone Institute article by public health physician Dr David Bell;
- Meryl Nass & Andrew Bridgen – Monkeypox & Other Matters: August 2024 interview with Liz Gunn at FreeNZ;
- South African group refutes WHO’s declaration of an mpox emergency and warns the public about the risks of the vaccines: August 2024 article in The Exposé;
- Professor Christian Perronne Interview – Monkeypox & The True Nature Of Public Health Organizations: 2022 Interview with France’s leading infectious disease expert;
- Exposing the Global Deception: Dr David Martin and Jonathan Otto (watch below).
This article was originally published by New Zealand Doctors Speaking Out With Science.
